Figures & data
Table 1 Number (%) of Study Participants with Specified Baseline Sociodemographic Characteristics
Table 2 Specified Baseline Characteristics of Eyes of Pilot Study Participants
Table 3 Number of Participants by Randomly Assigned Study Arm and Completion of Study Visits
Table 4 Number (Percent) of Study Eyes with Specified Usual-Corrected Visual Acuity (UCVA) at Baseline and Each Scheduled Follow-Up Clinic Visit
Table 5 Number (Percent) of Study Eyes with Specified Change in Usual-Corrected Visual Acuity (UCVA) from Baseline to Each Scheduled Follow-Up Clinic Visit
Table 6 Number (Percent) of Study Eyes with Specified Change in Central Subfield Thickness from Baseline to Each Follow-Up Clinic Visit
Table 7 Mean (Standard Deviation) Length of Scheduled Follow-Up Visits, in Minutes
Figure 1 (A) Mean length of each follow-up clinic visit for participants for whom a retinal examination was required at each clinic visit (Exam Group) and those for whom a retinal examination was required at only the 16-week and 32-week visits (No-Exam Group) . (B) Mean length of each follow-up clinic visit for participants from Exam Group at each clinic visit, those from No-Exam group who were examined at the visit, and those from No-Exam Group who were not examined at the visit.
Table 8 Number (Percentage) of Participants Who Rated “Clinic Waiting Time” as “Excellent” or “Very Good” When Interviewed After Specified Scheduled Follow-Up Visits
Table 9 Number (Percentage) of Participants Who Rated “Time Spent with Healthcare Professionals” as “Excellent” or “Very Good” During Interviews After Specified Scheduled Follow-Up Visits
Table 10 Number (Percentage) of Participants Who Rated “Visit Overall” as “Excellent” or “Very Good” During Interviews After Specified Scheduled Follow-Up Visits
Figure 2 (A) Percentage of participants in each group who responded “excellent” or “very good” to the question regarding satisfaction about “Length of waiting time(s)” with aspects of each follow-up clinic visit scheduled in the pilot study. (B) Percentage of participants in each group (Exam Group, No-Exam group who were examined at the visit, and No-Exam Group who were not examined at the visit), who responded “excellent” or “very good” to the question regarding satisfaction about “Length of waiting time(s)” with aspects of each follow-up clinic visit scheduled in the pilot study.
Figure 3 (A) Percentage of participants in each group who responded “excellent” or “very good” to the question regarding satisfaction about “Time spent with the ophthalmologist and other health care providers” with aspects of each follow-up clinic visit scheduled in the pilot study. (B) Percentage of participants in each group (Exam Group, No-Exam group who were examined at the visit, and No-Exam Group who were not examined at the visit), who responded “excellent” or “very good” to the question regarding satisfaction about “Time spent with the ophthalmologist and other health care providers” with aspects of each follow-up clinic visit scheduled in the pilot study.
Figure 4 (A) Percentage of participants in each group who responded “excellent” or “very good” to the question regarding satisfaction about “Overall clinic visit” with aspects of each follow-up clinic visit scheduled in the pilot study. (B) Percentage of participants in each group (Exam Group, No-Exam group who were examined at the visit, and No-Exam Group who were not examined at the visit), who responded “excellent” or “very good” to the question regarding satisfaction about “Overall clinic visit” with aspects of each follow-up clinic visit scheduled in the pilot study.
